Journal article 1297 views
Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial
Reinhard G Bretzel,
Ulrike Nuber,
Wolfgang Landgraf,
David Owens 
,
Clare Bradley,
Thomas Linn
,
Clare Bradley,
Thomas Linn
The Lancet, Volume: 371, Issue: 9618, Pages: 1073 - 1084
Swansea University Author:
David Owens
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1016/S0140-6736(08)60485-7
Abstract
Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial
| Published in: | The Lancet |
|---|---|
| Published: |
2008
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa13313 |
| College: |
Faculty of Medicine, Health and Life Sciences |
|---|---|
| Issue: |
9618 |
| Start Page: |
1073 |
| End Page: |
1084 |